Mitch Earleywine

Albany State University — United States

Medicine · Health Sciences

49h-index9.5kcitations283works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cannabis and Cannabinoid Research(76), Substance Abuse Treatment and Outcomes(71), Psychedelics and Drug Studies(50), Behavioral Health and Interventions(40), Neurotransmitter Receptor Influence on Behavior(28)

Publications280 total

Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms
Journal of Psychoactive Drugs·2025
Examining Volunteer Bias in Psychedelic Research
Journal of Psychoactive Drugs·2025
Variability in undergraduate academic stress: the role of ethnicity, early adverse family experiences, and psychological distress
Current Psychology·2025· 2 cited
A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS)
Psychoactives·2025Open Access
Intentional Choices of Metaphors for Psychedelic-Assisted Therapy
Cognitive and Behavioral Practice·2025· 1 citedOpen Access
Suicide after psychedelic-assisted treatment in context
Psychiatry Research·2025
Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing
Journal of Psychoactive Drugs·2024· 2 cited
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency
Journal of Psychoactive Drugs·2024Open Access
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
Journal of Psychopharmacology·2024· 5 cited
Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms
Journal of Psychedelic Studies·2024Open Access
Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects
Psychedelic Medicine·2024· 4 citedOpen Access
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
2024Open Access
An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment
Journal of Psychedelic Studies·2024· 4 citedOpen Access
Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study
Psychedelic Medicine·2024· 8 citedOpen Access
Protective Strategies for Psychedelics Scale
PsycTESTS Dataset·2024
Psilocybin Without Psychotherapy: A Cart Without a Horse?
American Journal of Psychiatry·2024· 18 cited
Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics
Journal of Psychopharmacology·2023· 6 citedOpen Access
Caregiver Maltreatment Subtypes and Timing: Differential Influences on Emerging Adulthood Empathy
Journal of Family Violence·2023
Expectancies for Subjective and Antidepressant Effects in Psilocybin Users
Journal of Humanistic Psychology·2023· 4 cited
The Therapeutic Alliance in Psychedelic-Assisted Psychotherapy: A Novel Target for Research and Interventions
Psychedelic Medicine·2023· 11 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Nicholas T. Van Dam(8), Joseph W. LaBrie(6), Ashley Borders(5), Christopher S. Martin(4), Sara Smucker Barnwell(4), Alison Looby(4), Sean C. Sheppard(3), Michael D. Newcomb(3), Jason Schiffman(3), Eric R. Pedersen(3), John P. Forsyth(2), Archana Jajodia(2), Sharon Danoff‐Burg(2), Peter Finn(2), Andréa L. Hobkirk(2), Peter R. Finn(2), Robert O. Pihl(2), Richard E. Musty(1), M W Perrine(1), Robert M. Swift(1)